Correlation Between NGM Biopharmaceutica and PsyBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both NGM Biopharmaceutica and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NGM Biopharmaceutica and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NGM Biopharmaceuticals and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on NGM Biopharmaceutica and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NGM Biopharmaceutica with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NGM Biopharmaceutica and PsyBio Therapeutics.
Diversification Opportunities for NGM Biopharmaceutica and PsyBio Therapeutics
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between NGM and PsyBio is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding NGM Biopharmaceuticals and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and NGM Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NGM Biopharmaceuticals are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of NGM Biopharmaceutica i.e., NGM Biopharmaceutica and PsyBio Therapeutics go up and down completely randomly.
Pair Corralation between NGM Biopharmaceutica and PsyBio Therapeutics
If you would invest 0.60 in PsyBio Therapeutics Corp on September 14, 2024 and sell it today you would lose (0.59) from holding PsyBio Therapeutics Corp or give up 98.33% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 0.37% |
Values | Daily Returns |
NGM Biopharmaceuticals vs. PsyBio Therapeutics Corp
Performance |
Timeline |
NGM Biopharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
PsyBio Therapeutics Corp |
NGM Biopharmaceutica and PsyBio Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with NGM Biopharmaceutica and PsyBio Therapeutics
The main advantage of trading using opposite NGM Biopharmaceutica and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NGM Biopharmaceutica position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.NGM Biopharmaceutica vs. Instil Bio | NGM Biopharmaceutica vs. Achilles Therapeutics PLC | NGM Biopharmaceutica vs. NextCure | NGM Biopharmaceutica vs. Assembly Biosciences |
PsyBio Therapeutics vs. Health Sciences Gr | PsyBio Therapeutics vs. Vg Life Sciences | PsyBio Therapeutics vs. MedMira | PsyBio Therapeutics vs. Oxford Cannabinoid Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |